B. Riley Forecasts Strong Price Appreciation for Lam Research (NASDAQ:LRCX) Stock

Lam Research (NASDAQ:LRCX) had its price target upped by equities research analysts at B. Riley from $180.00 to $195.00 in a research note issued on Thursday, MarketBeat Ratings reports. The firm currently has a “buy” rating on the semiconductor company’s stock. B. Riley’s price objective points to a potential upside of 13.19% from the company’s current price.

A number of other research firms have also recently weighed in on LRCX. Dbs Bank lifted their price objective on Lam Research from $119.40 to $184.20 in a research report on Monday, October 27th. Citigroup upped their price target on shares of Lam Research from $175.00 to $190.00 and gave the stock a “buy” rating in a research report on Tuesday, November 11th. Cantor Fitzgerald reissued an “overweight” rating and issued a $210.00 price objective on shares of Lam Research in a research note on Tuesday. Hsbc Global Res upgraded shares of Lam Research to a “hold” rating in a research note on Tuesday, September 30th. Finally, Evercore ISI upped their target price on shares of Lam Research from $115.00 to $170.00 and gave the stock an “outperform” rating in a report on Thursday, October 23rd. Twenty-six investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and an average price target of $160.37.

Lam Research Trading Up 4.6%

Shares of LRCX stock opened at $172.27 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The company has a market cap of $216.38 billion, a price-to-earnings ratio of 37.95, a PEG ratio of 1.69 and a beta of 1.77. Lam Research has a 1 year low of $56.32 and a 1 year high of $173.58. The firm has a fifty day moving average price of $154.83 and a 200-day moving average price of $122.80.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same period last year, the firm earned $0.86 EPS. Lam Research’s revenue for the quarter was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities analysts predict that Lam Research will post 3.71 earnings per share for the current year.

Insider Transactions at Lam Research

In related news, Director Bethany Mayer sold 1,298 shares of the stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the transaction, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the sale, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 102,608 shares of company stock valued at $14,916,496 over the last three months. Corporate insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Lam Research

A number of hedge funds have recently bought and sold shares of LRCX. IMG Wealth Management Inc. bought a new stake in shares of Lam Research in the 2nd quarter worth about $26,000. Stance Capital LLC purchased a new position in Lam Research in the third quarter worth about $26,000. Howard Hughes Medical Institute bought a new stake in Lam Research during the second quarter worth approximately $27,000. Triumph Capital Management bought a new stake in shares of Lam Research in the 3rd quarter valued at approximately $27,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the 2nd quarter valued at approximately $29,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Multiple sell‑side upgrades and price‑target increases from major firms lift sentiment and implied upside — B. Riley raised its target to $195 and maintained a buy rating. Article Title
• Positive Sentiment: Deutsche Bank raised its target to $195 and reiterated a buy, citing stronger forward visibility; that adds another institutional vote of confidence. Article Title
• Positive Sentiment: Mizuho lifted its price target to $200 from $170, maintaining an outperform view — another sizable increase that signals analysts expect stronger 2026 demand. Article Title
• Positive Sentiment: Coverage roundup: three firms turned bullish on LRCX today, a concentrated shift that drove short‑term buying interest. Article Title
• Positive Sentiment: Technical momentum: LRCX just flashed a golden‑cross (longer MA crossing above shorter MA) and cleared the 20‑day moving average — a buy signal that attracts momentum traders. Article Title
• Positive Sentiment: Investor recognition: IBD named Lam an “IBD Stock of the Day” and noted all‑time high momentum tied to 2026 prospects, which can attract retail inflows. Article Title
• Neutral Sentiment: Analysis pieces and price‑range summaries reflect consensus views and model updates (price forecasts shown from ~$175 to $210) — useful context but not a direct catalyst on its own. Article Title
• Neutral Sentiment: Feature coverage (Forbes) reviews the drivers behind today’s move and the 2026 thesis; good background for investors but largely descriptive. Article Title
• Neutral Sentiment: Corporate/community items (annual collegiate challenge winners) are positive PR but unlikely to move the stock materially. Article Title

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.